BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7740335)

  • 1. Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review.
    Vogel CL
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):61-5. PubMed ID: 7740335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
    Chang AY; Garrow GC
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience.
    Fumoleau P; Delozier T; Extra JM; Canobbio L; Delgado FM; Hurteloup P
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):22-8; discussion 28-9. PubMed ID: 7740332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life analyses from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer.
    Bertsch LA; Donaldson G
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):45-53; discussion 53-4. PubMed ID: 7740333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future directions for vinorelbine (Navelbine).
    Hortobagyi GN
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):80-6; discussion 86-7. PubMed ID: 7740338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: vinorelbine (navelbine) in non-small cell lung cancer.
    Crawford J
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined doxorubicin/vinorelbine (Navelbine) therapy in the treatment of advanced breast cancer.
    Hochster HS
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):55-9; discussion 59-60. PubMed ID: 7740334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinorelbine (Navelbine) in the treatment of breast cancer: a summary.
    Abeloff MD
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):1-4; discussion 41-4. PubMed ID: 7740330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.
    Drinkard LC; Hoffman PC; Samuels BL; Watson S; Bitran JD; Golomb HM; Vokes EE
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):30-7; discussion 41-4. PubMed ID: 7537911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine (Navelbine): study design and goals.
    Havlin K
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):38-40; discussion 41-4. PubMed ID: 7537912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
    Winer EP; Chu L; Spicer DV
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):72-8; discussion 78-9. PubMed ID: 7740337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
    Coltman CA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of unresectable non-small cell lung cancer.
    Livingston RB
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):4-11; discussion 11-3. PubMed ID: 7973768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.
    Chang AY; DeVore R; Johnson D
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.